海创药业: 简式权益变动报告书

Core Viewpoint - Chengdu Yingchuang Power Venture Capital Co., Ltd. has reduced its stake in Haichuang Pharmaceutical Co., Ltd. to 5% as part of its funding needs, resulting in a decrease of 5,617,669 shares from its previous holding of 10,568,449 shares, which represented 10.67% of the total shares before the reduction [1][4][10]. Group 1: Company Information - Haichuang Pharmaceutical Co., Ltd. is listed on the Shanghai Stock Exchange under the stock code 688302 [1]. - The registered address of Haichuang Pharmaceutical is located in the Chengdu High-tech Zone, Sichuan, China [1]. Group 2: Shareholding Changes - The shareholding change was executed without any additional conditions and was based on the information disclosed in the report [2]. - The reduction in shares occurred between July 12, 2023, and July 31, 2025, through centralized bidding and block trading [6]. - The average reduction price ranged from 24.82 to 63.17 yuan per share [6]. Group 3: Future Plans - Chengdu Yingchuang Power Venture Capital plans to continue evaluating its shareholding in Haichuang Pharmaceutical over the next 12 months, depending on market conditions and the company's business development [6][10]. - The company has announced a plan to reduce up to 1,980,310 shares, which has not yet been completed as of the report date [6]. Group 4: Impact on Company - The reduction in shareholding will not lead to a change in control of Haichuang Pharmaceutical and will not significantly impact its governance structure or ongoing operations [7].